Lifecore Biomedical Inc. Cash Flow-to-Debt Ratio
Lifecore Biomedical Inc. cash flow-to-debt ratio. Lifecore Biomedical Inc. (LFCR) has a Cash Flow-to-Debt Ratio of -0.01x as of May 2026, meaning its operating cash flow of $-2.19 Million could theoretically repay 0% of its total liabilities ($213.41 Million) in one year. Check Lifecore Biomedical Inc. cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Lifecore Biomedical Inc. (1996–2026)
Cash flow-to-debt ratio of Lifecore Biomedical Inc. from 1996 to 2026. Historical debt coverage capacity for Lifecore Biomedical Inc. across 30 annual periods. Check Lifecore Biomedical Inc. (LFCR) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Lifecore Biomedical Inc. Cash Flow-to-Debt Ratio by Year (1996–2026)
Lifecore Biomedical Inc. cash flow-to-debt ratio by year from 1996 to 2026. Year-by-year debt coverage analysis for Lifecore Biomedical Inc.. For the full cash flow conversion analysis, see cash flow conversion of Lifecore Biomedical Inc..
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | 0.05x | $12.57 Million | $246.38 Million | ▲ +5992.6% |
| 2025 | 0.00x | $-206.00K | $238.01 Million | ▼ -181.7% |
| 2024 | 0.00x | $257.00K | $242.65 Million | ▲ +100.9% |
| 2023 | -0.12x | $-22.59 Million | $186.88 Million | ▲ +7.2% |
| 2022 | -0.13x | $-24.40 Million | $187.22 Million | ▼ -337.5% |
| 2021 | 0.05x | $16.47 Million | $300.14 Million | ▲ +199.9% |
| 2020 | -0.05x | $-17.04 Million | $310.27 Million | ▼ -185.3% |
| 2019 | 0.06x | $16.02 Million | $248.95 Million | ▼ -50.5% |
| 2018 | 0.13x | $19.78 Million | $152.14 Million | ▼ -42.4% |
| 2017 | 0.23x | $29.33 Million | $129.86 Million | ▲ +35.9% |
| 2016 | 0.17x | $21.78 Million | $131.12 Million | ▼ -19.7% |
| 2015 | 0.21x | $26.16 Million | $126.36 Million | ▲ +7.1% |
| 2014 | 0.19x | $21.05 Million | $108.86 Million | ▲ +0.6% |
| 2013 | 0.19x | $21.23 Million | $110.53 Million | ▲ +9.2% |
| 2012 | 0.18x | $22.18 Million | $126.13 Million | ▼ -16.6% |
| 2011 | 0.21x | $14.47 Million | $68.59 Million | ▲ +90.9% |
| 2010 | 0.11x | $7.48 Million | $67.72 Million | ▼ -69.9% |
| 2009 | 0.37x | $9.44 Million | $25.67 Million | ▼ -27.5% |
| 2008 | 0.51x | $17.52 Million | $34.57 Million | ▲ +819.9% |
| 2007 | -0.07x | $-2.06 Million | $29.30 Million | ▼ -120.9% |
| 2006 | 0.34x | $10.87 Million | $32.20 Million | ▼ -31.4% |
| 2005 | 0.49x | $13.05 Million | $26.55 Million | ▲ +85.3% |
| 2004 | 0.27x | $7.93 Million | $29.91 Million | ▲ +13300.2% |
| 2002 | 0.00x | $-101.00K | $50.26 Million | ▲ +98.2% |
| 2001 | -0.11x | $-7.57 Million | $69.25 Million | ▼ -245.7% |
| 2000 | 0.08x | $5.01 Million | $66.73 Million | ▲ +118.6% |
| 1999 | -0.40x | $-3.60 Million | $8.90 Million | ▼ -3.5% |
| 1998 | -0.39x | $-3.40 Million | $8.70 Million | ▼ -3.7% |
| 1997 | -0.38x | $-5.50 Million | $14.60 Million | ▲ +81.2% |
| 1996 | -2.00x | $-3.60 Million | $1.80 Million | — |